Carpenter Philip M, Chen Wen-Pin, Mendez Aaron, McLaren Christine E, Su Min-Ying
Department of Pathology and Laboratory Medicine, University of California, Irvine Medical Center, 101 The City Dr., Orange, CA 92868, USA.
Int J Surg Pathol. 2011 Jun;19(3):335-41. doi: 10.1177/1066896909333511. Epub 2009 Apr 29.
Angiogenesis, the formation of blood vessels, is necessary for a tumor to grow, but when angiogenesis first appears in the progression of breast ductal carcinomas is unknown. To determine when this occurs, the authors examined microvessel density (MVD) by CD31 and CD105 immunostaining in normal ducts, 32 cases of usual hyperplasia, 19 cases of atypical hyperplasia, and 29 cases of ductal carcinoma in situ (DCIS). Simple hyperplasia had a 22-fold greater MVD than normal ducts (P < .0001). An increase during the progression of ductal changes was highly significant (P < .0001). To determine a possible mechanism, immunohistochemistry for vascular endothelial growth factor (VEGF) was evaluated. VEGF staining intensity of ductal epithelium increased during the progression from normal to hyperplastic to DCIS. This study shows that the first significant increase in angiogenesis occurs very early in the evolution of ductal proliferations as ductal cells become hyperplastic.
血管生成,即血管的形成,是肿瘤生长所必需的,但在乳腺导管癌进展过程中血管生成首次出现的时间尚不清楚。为了确定其发生时间,作者通过对正常导管、32例普通增生、19例非典型增生和29例导管原位癌(DCIS)进行CD31和CD105免疫染色来检测微血管密度(MVD)。单纯增生的MVD比正常导管高22倍(P <.0001)。在导管变化进展过程中的增加非常显著(P <.0001)。为了确定一种可能的机制,对血管内皮生长因子(VEGF)进行了免疫组织化学评估。从正常到增生再到DCIS的进展过程中,导管上皮的VEGF染色强度增加。这项研究表明,随着导管细胞增生,血管生成的首次显著增加发生在导管增生演变的早期。